Strokes Archives – The Bio Connection

Largest-Ever Genetic Study of Stroke Provides New Insight Into the Disease

March 29, 2018March 29, 2018 TheBioConnection Comment(0)

An international research group, including scientists at the University of Maryland School of Medicine, studying 520,000 people from around the world has identified 22 new genetic risk factors for stroke, tripling the number of gene regions known to affect stroke risk. The results show that stroke shares genetic influences with other vascular conditions, especially blood […]

Heart Health Strokes

Study: Breastfeeding Moms May Be at Lower Risk of Heart Attack and Stroke

July 6, 2017July 5, 2017 TheBioConnection Comment(0)

We have known for a long time that breastfeeding is healthy for babies; however studies have shown that it can provide long term health benefits for the moms too. This new information comes from recent research published in the Journal of the American Heart Association. The comprehensive study followed 300,000 adult women in China. Previous […]

New target protein for colon cancer identified July 17, 2018
Researchers have identified a new potential target protein (c-Cbl) they believe can help further the understanding of colon cancer and ultimately survival of patients with the disease.
Early supper associated with lower risk of breast and prostate cancer July 17, 2018
People who have their evening meal before 9 p.m. or wait at least two hours before going to sleep have lower risk of breast and prostate cancer.
Protein found to be key component in irregularly excited brain cells July 17, 2018
In a new study in mice, researchers have identified a key protein involved in the irregular brain cell activity seen in autism spectrum disorders and epilepsy. The protein, p53, is well-known in cancer biology as a tumor suppressor.
Allergic responses may protect against skin cancer July 17, 2018
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings.
Tackling cancer at ground zero with designer molecules July 17, 2018
A new molecule shows great promise for future treatment of many cancers.
'Invisible' stool blood linked to heightened risk of death from all causes July 17, 2018
'Invisible' blood detected in the stools is linked to a heightened risk of death from all causes, as well as from bowel cancer, reveals research published online in the journal Gut.
Breast cancer follow-up imaging varies widely, study finds July 16, 2018
Follow-up imaging for women with non-metastatic breast cancer varies widely across the country, according to a new study. Some patients go without the annual mammograms that experts recommend, while others with the same cancer diagnosis receive full-body scans that expose them to significant amounts of radiation and are not recommended by experts.
Magnetized wire could be used to detect cancer in people July 16, 2018
A magnetic wire used to snag scarce and hard-to-capture tumor cells could prove to be a swift and effective tactic for early cancer detection, according to a new study.
Cancer researchers suggest new treatment for rare inherited cancers July 16, 2018
Studying two rare inherited cancer syndromes, scientists have found the cancers are driven by a breakdown in how cells repair their DNA. The discovery suggests a promising strategy for treatment with drugs recently approved for other forms of cancer, said the researchers.
Weight loss surgery may affect the risk of cancer July 16, 2018
A new analysis indicates that weight loss surgery may affect an individual's risk of developing cancer.

Scancell Holdings inks drug delivery technology deal July 18, 2018
It has exercised an option on TriGrid, which was developed by Ichor Medical Systems
NetScientific’s Wanda enhances Patient Management Platform with patient adherence features July 18, 2018
The AIM-listed firm said the use of Wanda’s existing platform had been shown to predict 90% of patient-level adverse events up to seven days in advance of their occurrence and allows for virtual intervention to prevent such events
SkinBioTherapeutics receives ethics approval for human trial of SkinBiotix July 18, 2018
“Ethics approval is a prerequisite for human clinical trials and therefore required before our human study can commence”
Cellectar Biosciences shares rollercoaster after one patient sees a 94% tumor reduction in its mid-stage trial July 17, 2018
The Phase 2 trial of its drug CLR 131 will enroll a total of 80 patients and continue until March 2019
Orgenesis revenue nearly doubled in fiscal second quarter on CAR T-cell therapies July 17, 2018
CEO Vered Caplan attributes his company's revenue growth to an expansion of services, particularly CAR T-cell therapies
PetVivo Holdings switches from treating humans to horses July 17, 2018
PetVivo Holdings Inc (OTCMKTS:PETV) President John Lai tells Proactive Investors how the two-decade-old company went from treating humans to horses. The biomedical device company developed degenerative medicine for humans for over 15 years before switching to veterinary medicine. Around two weeks ago, the company introduced an injectable treatment for osteoarthritis in horses and dogs called […]
VentriPoint Diagnostics' innovative tech under the spotlight as word leading cardiac centre kicks off study July 17, 2018
Clinicians will be using the firm's tech to analyze poor quality ultrasound images.
Daily CryptoCann™ Report: Coinbase may soon trade coins as securities; Aphria expands into Latin America and the Caribbean July 17, 2018
The SEC and FINRA have approved acquisitions that will allow the exchange to operate as a broker-dealer
Mackie Research reiterates Buy rating on WeedMD after end of merger agreement with Hiku Brands July 17, 2018
Analyst Greg McLeish says the investment thesis remains intact and keeps a C$4 target price on the stock
ChemioCare advancing 'potentially revolutionary' chemo-induced nausea treatment July 17, 2018
ChemioCare CEO Pedro Lichtinger caught up with Proactive's Andrew Scott while in London. Lichtinger outlines the company's vision which is to transform the current treatment of chemotherapy-induced nausea and vomiting through patch technology. He says the first patch in their pipeline has completed its development in the lab, it's gone through several tests which prove […]

STAT Plus: Pharmalittle: Hugin pushes back on ad that claims he ‘made a killing’; FDA warns about warning letter scam July 16, 2018
Scam artists posing as employees from the FDA are issuing official-looking letters to those who have tried to buy prescription medicines from illegal online pharmacies.
STAT Plus: Lawmaker asks Pfizer to make recent rollback on drug prices permanent July 16, 2018
“Instead of playing games with the costs of prescription drugs that millions of Americans depend on, you should make a firm and clear commitment to permanently roll back prices,” Sen.…
STAT Plus: Novartis handling of Cohen deal adds to its ‘ledger of corporate wrongdoing,’ critic charges July 13, 2018
A report released by Senate Democrats throws into question Novartis' claims of a newfound conviction to rework the corporate culture.
STAT Plus: Up and down the ladder: The latest comings and goings July 13, 2018
Everyone wants to know who is coming and going.
STAT Plus: Pharmalittle: J&J ordered to pay $4.7 billion over baby powder cancer links; Novartis and Trump lawyer were tighter than thought July 13, 2018
The relationship between President Trump’s personal attorney, Michael Cohen, and Novartis was more extensive than the drug maker previously disclosed.
STAT Plus: Drug wholesalers sue New York over an opioid stewardship program July 12, 2018
The Healthcare Distribution Alliance argues the law unfairly singles out companies to “bear liability for a complex public health epidemic.”
STAT Plus: Novartis is the latest big drug maker to exit antibiotic research July 12, 2018
"More drug makers are shying away from innovation. Previously, Lilly, then AstraZeneca, now part of Novartis. ... Who’s next?”
STAT Plus: Pharmalittle: Most drug price hikes occurred before Azar arrived; Novartis abandons antibiotics July 12, 2018
Novartis is closing its antibiotic and antiviral research operations in the San Francisco Bay area and cutting about 140 jobs
STAT Plus: Cummings probes Trump administration official over potential conflicts with drug maker July 11, 2018
A former Gilead lobbyist was working in the Trump administration with Novartis to develop a payment model at the same time Gilead was seeking to buy the same kind of…
STAT Plus: Lawmaker wants to know if Trump and Pfizer cut any secret deals July 11, 2018
“Secret, sweetheart arrangements with pharmaceutical companies are exactly why America’s drug pricing system is broken,” Sen. Ron Wyden (D-Ore.) said.

Poxel Announces Favorable Results for PXL770 Phase 1b Multiple Ascending Dose Trial and Drug-Drug Interaction Study
PXL770 observed to have a favorable safety and pharmacokinetic profile in the complete Phase 1 program
BIO Applauds House Passage of the JOBS and Investor Confidence Act of 2018
The JOBS and Investor Confidence Act of 2018, which includes the Fostering Innovation Act, provides much needed regulatory relief for pre-revenue innovators
EUSA Pharma Announces Acquisition of Global Rights to SYLVANT® (siltuximab) from Janssen Sciences Ireland UC for $115 Million
Acquisition significantly boosts EUSA Pharma’s presence as a global biopharmaceutical company in oncology and rare disease
FDA Grants Breakthrough Therapy Designation for Genentech’s TECENTRIQ in Combination With Avastin as First-Line Treatment for Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Genentech announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for TECENTRIQ® (atezolizumab)
New Epilepsy Research at Baylor College of Medicine Provides Insight on Absen...
Absence epilepsy is the most common type of seizure disorder in children and is the focus of a new neurology study at Baylor College of Medicine and published in the journal Nature Communications.
Puma Biotechnology and Strata Oncology Announce Collaboration to Accelerate Enrollment in Neratinib HER2 Mutation Basket Study (SUMMIT Trial)
Puma Biotechnology, Inc. and Strata Oncology, Inc. have entered into a collaborative agreement to accelerate patient enrollment in Puma’s ongoing Phase II SUMMIT trial of PB272 (neratinib).
APEIRON Appoints Peter Llewellyn-Davies as Chief Executive Officer
The former CEO Dr. Hans Loibner will continue to support the Company as senior advisor
leon-nanodrugs Supports Takeda in a Feasibility Assessment of leon’s Proprietary MicroJet Reactor (MJR®) Nano-Technology
leon-nanodrugs GmbH's proprietary MicroJet Reactor nano-technology has been selected by Takeda Pharmaceutical Company Ltd. for a feasibility assessment that could potentially lead to the development of an innovative formulation of one of their current pipeline products.
Colorado BioScience Association Announces Departure of President & CEO, April Giles
Colorado BioScience Association (CBSA) announces the departure of longtime President & CEO April Giles.
Inflection Biosciences Announces Publication of Positive Data for Dual Mechanism Inhibitor Against Chronic Lymphocytic Leukaemia
Inflection Biosciences Ltd announced the publication of preclinical data showing the company’s dual mechanism PIM/PI3 kinase inhibitor IBL-202 has promise as a treatment for chronic lymphocytic leukaemia (CLL).